These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31505678)

  • 41. FDA's review of scientific evidence for health claims.
    Schneeman B
    J Nutr; 2007 Feb; 137(2):493-4. PubMed ID: 17237334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The science and regulations of probiotic food and supplement product labeling.
    Sanders ME; Levy DD
    Ann N Y Acad Sci; 2011 Feb; 1219 Suppl 1():E1-E23. PubMed ID: 21332758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(57):14451. PubMed ID: 10558410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34959-69. PubMed ID: 17674485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Athlete Information Sources About Dietary Supplements: A Review of Extant Research.
    Denham BE
    Int J Sport Nutr Exerc Metab; 2017 Aug; 27(4):325-334. PubMed ID: 28388288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
    McNamara SH
    Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
    [No Abstract]   [Full Text] [Related]  

  • 47. Label claims for foods and supplements: a review of the regulations.
    Turner RE; Degnan FH; Archer DL
    Nutr Clin Pract; 2005 Feb; 20(1):21-32. PubMed ID: 16207644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
    Melethil S
    Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Why consumers need more protection against claims for dietary supplements and herbs.
    Barrett S
    Int J Toxicol; 2003; 22(5):391-2. PubMed ID: 14555413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time for Change: Stepping Up the FDA's Regulation of Dietary Supplements to Promote Consumer Safety and Awareness.
    Kennett G
    J Law Health; 2019; 33(1):47-78. PubMed ID: 31841617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dietary supplement safety information in magazines popular among older readers.
    Kava R; Meister KA; Whelan EM; Lukachko AM; Mirabile C
    J Health Commun; 2002; 7(1):13-23. PubMed ID: 11878567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health claims in the United States: an aid to the public or a source of confusion?
    Hasler CM
    J Nutr; 2008 Jun; 138(6):1216S-20S. PubMed ID: 18492860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. History and overview of DSHEA.
    Dickinson A
    Fitoterapia; 2011 Jan; 82(1):5-10. PubMed ID: 20837113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naturally complex: Perspectives and challenges associated with Botanical Dietary Supplement Safety assessment.
    Shipkowski KA; Betz JM; Birnbaum LS; Bucher JR; Coates PM; Hopp DC; MacKay D; Oketch-Rabah H; Walker NJ; Welch C; Rider CV
    Food Chem Toxicol; 2018 Aug; 118():963-971. PubMed ID: 29626579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mission impossible? Regulatory and enforcement issues to ensure safety of dietary supplements.
    Petroczi A; Taylor G; Naughton DP
    Food Chem Toxicol; 2011 Feb; 49(2):393-402. PubMed ID: 21087651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective.
    Collins N; Tighe AP; Brunton SA; Kris-Etherton PM
    J Am Coll Nutr; 2008 Dec; 27(6):659-66. PubMed ID: 19155425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary Supplements: Foods, Medicines, or Both? A Controversial Designation with Unspecific Legislation.
    Pereira C; Barros L; Ferreira ICFR
    Curr Pharm Des; 2017; 23(19):2722-2730. PubMed ID: 28124610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Dietary Supplement Health and Education Act.
    Young AL; Bass IS
    Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
    [No Abstract]   [Full Text] [Related]  

  • 59. Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health.
    Hass DJ; Lewis JD
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):578-86. PubMed ID: 16700078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of cGMP compliance on consumer confidence in dietary supplement products.
    Crowley R; FitzGerald LH
    Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.